▁ 4.1328125
8 3.8515625
% 6.42578125
▁of 1.068359375
▁the 2.35546875
▁residents 6.453125
▁of 0.72900390625
▁progress 12.5859375
ive 0.0445556640625
▁countries 6.57421875
▁have 2.39453125
▁chron 5.8828125
ic 0.01983642578125
▁pain 1.9951171875
, 1.76171875
▁which 2.646484375
▁is 0.724609375
▁considered 4.58203125
▁to 1.259765625
▁be 0.044769287109375
▁an 2.578125
▁extreme 5.44140625
▁issue 5.27734375
. 0.9345703125
<0x0A> 1.5771484375
There 3.833984375
▁is 1.650390625
▁a 0.91064453125
▁lack 4.29296875
▁of 0.01107025146484375
▁information 3.140625
▁about 1.0380859375
▁the 0.849609375
▁effects 4.44921875
▁of 0.09954833984375
▁op 4.06640625
iate 4.296875
▁dru 2.376953125
gs 1.8835067749023438e-05
. 2.203125
<0x0A> 0.861328125
The 2.05078125
▁data 6.09765625
▁was 3.8125
▁analyz 3.724609375
ed 0.0008406639099121094
▁in 2.46484375
▁a 1.974609375
▁study 1.1865234375
. 3.9296875
<0x0A> 0.69677734375
This 4.36328125
▁type 4.66796875
▁of 0.0031528472900390625
▁study 3.171875
▁is 1.390625
▁the 2.8828125
▁most 2.20703125
▁reve 6.5703125
aling 0.0015811920166015625
▁and 2.400390625
▁inclus 6.8203125
ive 0.0009860992431640625
, 2.740234375
▁as 1.751953125
▁it 0.4775390625
▁contains 3.912109375
▁direct 7.5859375
▁responses 5.46875
▁from 0.417236328125
▁a 3.32421875
▁large 1.111328125
▁number 0.48388671875
▁of 0.002979278564453125
▁participants 2.78515625
. 0.431396484375
▁All 6.40625
▁tools 10.3125
▁in 3.8515625
▁the 0.62646484375
▁form 5.2421875
▁of 0.04071044921875
▁question 0.94921875
na 0.0062103271484375
ires 4.410743713378906e-05
▁and 1.837890625
▁scales 3.52734375
▁have 3.052734375
▁already 4.3203125
▁been 0.176513671875
▁used 2.787109375
▁and 2.72265625
▁proved 4.1796875
▁their 1.1787109375
▁effic 4.3359375
acy 0.0101470947265625
▁for 4.3359375
▁collect 3.21484375
ing 0.0017843246459960938
▁analyt 8.3125
ical 0.06146240234375
▁data 0.384521484375
. 0.302490234375
▁It 4.28125
▁helps 5.04296875
▁to 0.36572265625
▁system 5.70703125
at 0.1259765625
ize 0.004390716552734375
▁and 1.5595703125
▁class 4.140625
ify 0.0007348060607910156
▁distinct 10.59375
▁kinds 6.91796875
▁of 0.0147247314453125
▁information 1.4619140625
▁for 4.66796875
▁subsequent 4.6328125
▁un 8.0078125
comp 4.2890625
licated 0.0183868408203125
▁services 11.671875
. 0.74267578125
▁Thus 5.9453125
, 0.0271148681640625
▁research 4.44140625
ers 0.5283203125
▁can 1.7451171875
▁compare 3.83203125
▁the 1.0078125
▁effects 4.61328125
▁of 0.12548828125
▁medic 3.2578125
ations 0.56494140625
▁on 1.8427734375
▁patients 2.171875
▁of 3.333984375
▁diverse 5.5546875
▁age 1.4677734375
▁groups 1.228515625
, 0.923828125
▁background 4.7890625
s 0.1407470703125
, 0.121337890625
▁physical 5.52734375
▁conditions 2.025390625
, 0.1607666015625
▁emot 7.25
ional 0.036712646484375
▁states 1.0830078125
, 0.1533203125
▁and 0.52880859375
▁so 2.181640625
▁on 0.17626953125
. 0.059112548828125
<0x0A> 0.458984375
The 1.337890625
▁analysis 4.5859375
▁of 0.77783203125
▁any 7.07421875
▁human 7.58203125
▁reaction 4.27734375
▁has 4.14453125
▁a 1.814453125
▁high 3.5390625
▁potential 3.69921875
▁of 2.306640625
▁subject 4.91015625
iveness 3.552734375
▁and 1.7685546875
▁bias 2.306640625
. 0.603515625
<0x0A> 3.083984375
The 1.4794921875
▁study 2.5625
▁included 3.7890625
▁ 1.0029296875
8 3.078125
9 2.837890625
0 2.3828125
▁participants 2.435546875
, 1.9736328125
▁of 2.91796875
▁which 0.424072265625
▁ 0.16162109375
4 1.685546875
7 2.4609375
4 2.89453125
▁were 0.68896484375
▁treated 4.8359375
▁sole 7.14453125
ly 2.002716064453125e-05
▁with 0.140380859375
▁op 0.483642578125
io 0.9599609375
ids 0.344482421875
, 0.69970703125
▁ 1.1318359375
3 1.3857421875
2 2.279296875
9 2.484375
▁were 1.7275390625
▁treated 0.76318359375
▁with 0.199462890625
▁MM 10.6328125
, 2.44921875
▁and 0.2449951171875
▁ 0.1680908203125
7 2.912109375
7 0.2548828125
▁were 0.74365234375
▁treated 0.421142578125
▁with 0.08660888671875
▁place 3.73046875
bo 0.46435546875
. 0.2403564453125
<0x0A> 1.1279296875
The 1.0029296875
▁study 2.40625
▁conducted 5.7109375
▁a 2.890625
▁correlation 6.73046875
▁type 9.125
▁of 0.578125
▁research 1.3720703125
▁with 3.5234375
▁variable 8.2265625
▁measures 5.015625
. 0.98095703125
▁It 2.46875
▁evaluated 6.30078125
▁the 0.454345703125
▁inter 7.0234375
dep 2.77734375
end 0.00038886070251464844
ence 0.01055145263671875
▁of 0.476318359375
▁various 3.35546875
▁factors 1.15625
▁that 2.697265625
▁affected 3.673828125
▁the 0.290283203125
▁physical 5.515625
▁and 0.62255859375
▁emot 0.9716796875
ional 0.00014841556549072266
▁condition 2.115234375
▁of 0.087646484375
▁patients 1.296875
▁experien 6.91796875
cing 6.079673767089844e-06
▁chron 0.37353515625
ic 0.0004775524139404297
▁pain 0.050323486328125
. 0.155029296875
▁For 5.0546875
▁example 1.181640625
, 0.0103607177734375
▁the 1.0107421875
▁survey 5.78125
▁showed 3.310546875
▁that 0.316162109375
▁the 1.521484375
▁ratio 6.91796875
▁of 0.1142578125
▁female 4.77734375
▁patients 1.080078125
▁was 1.4091796875
▁remark 9.4765625
ably 0.00024509429931640625
▁higher 0.243408203125
▁in 2.6875
▁the 0.6787109375
▁op 2.3125
i 3.7578125
ates 0.053375244140625
▁group 0.259033203125
▁compared 2.62109375
▁to 0.1396484375
▁the 0.489501953125
▁MM 0.94775390625
▁group 0.404052734375
. 0.272705078125
▁In 3.181640625
▁turn 3.900390625
, 0.0018415451049804688
▁people 5.82421875
▁on 4.88671875
▁op 2.51953125
i 0.421142578125
ates 0.0027217864990234375
▁were 1.27734375
▁more 1.203125
▁likely 0.475341796875
▁to 0.02349853515625
▁report 2.564453125
▁major 7.1640625
▁de 0.5244140625
press 0.79345703125
ive 0.005199432373046875
▁dis 0.619140625
orders 1.4072265625
. 1.4423828125
<0x0A> 0.82568359375
The 1.052734375
▁variables 7.85546875
▁used 2.990234375
▁to 2.10546875
▁collect 3.142578125
▁information 1.7958984375
▁were 1.1455078125
▁gender 3.94921875
, 0.080322265625
▁age 0.70703125
, 0.04998779296875
▁country 5.15234375
, 1.1787109375
▁type 2.82421875
▁of 0.0550537109375
▁residence 7.16796875
, 0.1783447265625
▁and 1.9208984375
▁years 6.39453125
▁of 0.270263671875
▁education 2.337890625
. 0.1199951171875
<0x0A> 0.95849609375
Am 6.0
ong 0.0112762451171875
▁all 2.388671875
▁participants 2.568359375
▁in 3.39453125
▁the 0.151123046875
▁study 0.67138671875
, 0.062225341796875
▁ 0.77978515625
4 2.12109375
2 2.37890625
. 1.1640625
2 2.228515625
% 0.11749267578125
▁suffered 3.35546875
▁from 0.048492431640625
▁de 2.56640625
pression 0.2578125
, 0.87451171875
▁and 1.7060546875
▁ 0.346923828125
3 1.53125
7 2.365234375
% 2.357421875
▁experienced 2.8359375
▁excess 7.3203125
ive 0.025848388671875
▁anx 1.4541015625
iety 0.0008192062377929688
. 0.1627197265625
▁The 2.416015625
▁pl 10.40625
ur 0.85986328125
ality 0.0013170242309570312
▁of 0.12261962890625
▁de 3.177734375
press 1.4169921875
ive 0.05914306640625
▁dis 1.921875
orders 0.059326171875
▁among 3.6328125
▁patients 1.4345703125
▁in 2.79296875
▁the 0.203125
▁op 0.4990234375
i 0.55810546875
ates 0.0020847320556640625
, 8.0390625
▁medical 6.8359375
▁mar 0.378662109375
iju 0.0021991729736328125
ana 0.0001608133316040039
, 0.330078125
▁and 0.042724609375
▁mixed 7.05859375
▁OP 12.046875
MM 5.73046875
▁groups 0.369140625
▁number 8.6875
ed 0.0131378173828125
▁ 0.15576171875
5 1.884765625
7 2.623046875
. 0.41162109375
1 2.529296875
%, 0.2227783203125
▁ 0.0039825439453125
2 1.5986328125
2 2.546875
. 0.1114501953125
3 2.2734375
%, 0.07562255859375
▁and 0.03277587890625
▁ 0.0015478134155273438
5 2.62109375
1 2.033203125
. 0.16357421875
4 1.0400390625
%, 0.1258544921875
▁respectively 0.0247650146484375
. 0.0205230712890625
▁The 1.9267578125
▁pl 4.0234375
ur 0.01000213623046875
ality 5.519390106201172e-05
▁of 0.027008056640625
▁anx 0.45556640625
iety 0.018035888671875
▁contained 11.078125
▁ 0.28076171875
4 1.1640625
8 2.3125
. 0.184814453125
4 2.220703125
% 2.359375
▁among 2.998046875
▁OP 4.921875
▁patients 5.35546875
, 0.219970703125
▁ 0.11273193359375
2 0.8974609375
1 2.353515625
. 0.12030029296875
5 2.130859375
% 0.03607177734375
▁among 0.51953125
▁MM 0.1746826171875
▁patients 0.37109375
, 0.0361328125
▁and 0.0174560546875
▁ 0.029541015625
3 1.388671875
8 2.0546875
. 0.125244140625
7 2.763671875
% 0.01214599609375
▁among 0.202392578125
▁OP 2.39453125
MM 0.294189453125
▁participants 3.740234375
. 0.022216796875
▁Pat 6.1171875
ients 0.01503753662109375
▁who 1.8671875
▁took 2.17578125
▁strong 8.984375
▁op 0.591796875
i 0.58056640625
ates 0.003597259521484375
▁were 1.1806640625
▁t 9.9765625
ended 1.4931640625
▁to 0.01006317138671875
▁place 9.4296875
▁their 2.5703125
▁pain 2.923828125
▁on 1.2822265625
▁a 0.78125
▁scale 1.7626953125
▁of 0.409912109375
▁ 0.1431884765625
9 2.37109375
▁to 2.267578125
▁ 0.01039886474609375
1 0.010009765625
0 0.05322265625
▁( 2.927734375
Fe 11.359375
ing 5.70703125
old 0.380126953125
▁et 1.662109375
▁al 0.017974853515625
., 0.254150390625
▁ 0.01122283935546875
2 0.0693359375
0 0.0002605915069580078
1 0.347412109375
7 1.755859375
). 0.03546142578125
▁They 5.26171875
▁were 1.6357421875
▁also 1.0458984375
▁an 9.5
gu 3.2890625
ished 0.071044921875
▁em 6.14453125
otion 0.0012388229370117188
ally 0.0007224082946777344
▁and 1.0078125
▁react 7.7265625
ed 0.0228729248046875
▁rad 8.7734375
ically 0.0009326934814453125
▁neg 5.1328125
atively 0.0013942718505859375
▁to 0.2120361328125
▁almost 5.91015625
▁all 1.30078125
▁survey 4.5859375
▁questions 0.46630859375
. 0.3046875
▁Pat 3.982421875
ients 0.007381439208984375
▁who 1.0263671875
▁took 1.27734375
▁only 5.30078125
▁MM 0.31005859375
▁or 2.5859375
▁mixed 2.197265625
▁medic 2.0
ations 0.2421875
▁course 13.8515625
▁had 2.525390625
▁a 1.20703125
▁significantly 3.298828125
▁more 2.544921875
▁stable 3.681640625
▁emot 1.14453125
ional 0.0012159347534179688
▁state 0.3896484375
▁and 1.21484375
▁cop 6.9296875
ed 0.053466796875
▁with 0.466064453125
▁pain 1.0634765625
▁more 1.8388671875
▁manage 7.6796875
able 1.2578125
. 0.33935546875
<0x0A> 0.405517578125
The 1.091796875
▁weak 8.2578125
▁focus 10.6953125
▁of 0.623046875
▁respond 7.484375
ents 0.059783935546875
▁who 2.77734375
▁have 4.8984375
▁overcome 8.0625
▁pain 2.45703125
▁and 2.341796875
▁de 3.05859375
pression 0.114013671875
▁is 2.267578125
▁the 1.9599609375
▁reason 4.21484375
▁for 0.447021484375
▁the 0.8203125
▁high 2.88671875
▁response 5.5703125
▁rate 0.41064453125
. 1.08984375
